HomeCompareRELV vs JNJ

RELV vs JNJ: Dividend Comparison 2026

RELV yields 96.57% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RELV wins by $3.35M in total portfolio value
10 years
RELV
RELV
● Live price
96.57%
Share price
$2.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.38M
Annual income
$1,113,866.13
Full RELV calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — RELV vs JNJ

📍 RELV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRELVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RELV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RELV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RELV
Annual income on $10K today (after 15% tax)
$8,208.59/yr
After 10yr DRIP, annual income (after tax)
$946,786.21/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, RELV beats the other by $942,748.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RELV + JNJ for your $10,000?

RELV: 50%JNJ: 50%
100% JNJ50/50100% RELV
Portfolio after 10yr
$1.71M
Annual income
$559,308.00/yr
Blended yield
32.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RELV
No analyst data
Altman Z
0.7
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RELV buys
0
JNJ buys
0
No recent congressional trades found for RELV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRELVJNJ
Forward yield96.57%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$3.38M$30.5K
Annual income after 10y$1,113,866.13$4,749.88
Total dividends collected$3.01M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RELV vs JNJ ($10,000, DRIP)

YearRELV PortfolioRELV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$20,357$9,657.17$10,594$274.49+$9.8KRELV
2$40,155$18,373.15$11,294$360.69+$28.9KRELV
3$76,837$33,870.80$12,133$476.91+$64.7KRELV
4$142,787$60,571.58$13,156$635.42+$129.6KRELV
5$257,979$105,197.14$14,432$854.61+$243.5KRELV
6$453,668$177,629.88$16,056$1,162.76+$437.6KRELV
7$777,359$291,934.37$18,175$1,604.53+$759.2KRELV
8$1,299,278$467,503.71$21,009$2,252.68+$1.28MRELV
9$2,120,494$730,267.02$24,911$3,229.73+$2.10MRELV
10$3,382,795$1,113,866.13$30,458$4,749.88+$3.35MRELV

RELV vs JNJ: Complete Analysis 2026

RELVStock

Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.

Full RELV Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RELV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RELV vs SCHDRELV vs JEPIRELV vs ORELV vs KORELV vs MAINRELV vs ABBVRELV vs MRKRELV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.